Jun 16, 2026 09:05AM
Jun 16, 2026 09:05AM
May 20, 2026 04:20PM
May 20, 2026 04:20PM
May 18, 2026 09:05AM
May 18, 2026 09:05AM
May 4, 2026 04:05PM BioMarin Reports First Quarter 2026 Financial and Operating Results
May 4, 2026 05:54AM
May 2, 2026 03:30PM
Apr 27, 2026 08:44AM
Apr 27, 2026 08:44AM
Apr 21, 2026 04:24PM
Apr 21, 2026 04:23PM
Mar 12, 2026 09:05AM BioMarin reports early VOXZOGO treatment benefits for achondroplasia
Mar 12, 2026 09:05AM
Mar 2, 2026 04:34PM
Feb 27, 2026 08:00PM
Feb 25, 2026 06:38AM
Feb 23, 2026 04:05PM
Feb 18, 2026 05:31PM
Feb 12, 2026 07:41AM BioMarin (BMRN), Ascendis (ASND) Trade Lower Following Competitor Data
Dec 19, 2025 07:45AM
Dec 19, 2025 07:45AM
Oct 29, 2025 09:01AM
Oct 29, 2025 09:00AM
Oct 28, 2025 06:41AM
Oct 27, 2025 04:03PM
Sep 8, 2025 09:00AM BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting
Sep 6, 2025 11:05AM
Sep 6, 2025 11:05AM
Aug 30, 2025 04:00PM
Aug 4, 2025 04:02PM
Jul 15, 2025 06:15AM
Jun 25, 2025 10:03AM
Jun 24, 2025 09:02AM BioMarin Pharma (BMRN) Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN at International Society on Thrombosis and Haemostasis 2025 Congress
Jun 24, 2025 09:00AM
Jun 5, 2025 12:44PM
May 12, 2025 09:06AM
May 12, 2025 09:05AM
May 1, 2025 04:05PM
Apr 10, 2025 05:32AM
Apr 2, 2025 09:06AM BioMarin Pharma (BMRN) Announces Positive Pivotal Data for PALYNZIQ in Adolescents with Phenylketonuria
Apr 2, 2025 09:00AM
Mar 20, 2025 09:00AM
Mar 11, 2025 07:05AM
Feb 19, 2025 04:05PM
Nov 30, 2024 04:00AM
Nov 16, 2024 10:45AM
Oct 29, 2024 04:03PM BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
Sep 18, 2024 08:00AM

323,900 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All